Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Operative risk of geriatric patients in cardiac surgery].

Zeitschrift fur Gerontologie und Geriatrie·2018
Same author

[Pharmacist rounds on geriatric wards : Assessment of 1 year of pharmaceutical counseling].

Zeitschrift fur Gerontologie und Geriatrie·2016
Same author

[Dementia-friendly hospital wards : Expert recommendations for planning and design].

Zeitschrift fur Gerontologie und Geriatrie·2016
Same author

[Comorbid diseases of dementia].

Zeitschrift fur Gerontologie und Geriatrie·2015
Same author

[Diabetes mellitus and dementia].

Der Internist·2015
Same author

[Special care units for acutely ill patients with cognitive impairment in Germany. Position paper].

Zeitschrift fur Gerontologie und Geriatrie·2014

Related Experiment Video

Updated: May 10, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

[Dementia: diagnosis and therapy].

D Kopf1, A Rösler

  • 1Klinik für Geriatrie, Zentrum für Klinische Psychologie und Psychotherapie, Kath. Marienkrankenhaus, Alfredstr. 9, 22087 Hamburg, Deutschland. kopf.geriatrie@marienkrankenhaus.org

Der Internist
|June 20, 2013
PubMed
Summary
This summary is machine-generated.

Dementia involves progressive memory loss, often Alzheimer's disease. Diagnosis requires cognitive tests and imaging, with treatment focusing on symptoms and complications.

Related Experiment Videos

Last Updated: May 10, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Area of Science:

  • Neurology
  • Internal Medicine

Context:

  • Dementia is a syndrome of progressive cognitive decline, primarily characterized by memory loss.
  • Alzheimer's disease is the most common cause, but differential diagnosis includes other neurodegenerative diseases, vascular dementia, and reversible conditions like delirium or depression.

Purpose:

  • To provide a comprehensive overview of current clinical knowledge regarding dementia.
  • To highlight the internal medicine perspective on managing dementia and its complications.

Summary:

  • Diagnostic evaluation involves standardized cognitive testing, neuroimaging, and laboratory tests.
  • Treatment strategies address cognitive, psychiatric, and behavioral symptoms, alongside managing medical complications and establishing social support.

Impact:

  • This review aims to inform clinicians on the multifaceted approach to dementia care.
  • Emphasis is placed on the prevention and treatment of medical complications relevant to internal medicine specialists.